Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression

Atherosclerosis

Volumn 202, Issue 2, 2009, Pages 415-423

  Wågsäter, Dick ^a   Zhu, Chaoyong ^a   Björck, Hanna M ^b   Eriksson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Extracellular matrix; Growth factor; Protease

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ASSAY; CELL DIFFERENTIATION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER;

AUTOCRINE COMMUNICATION; CAROTID ARTERY DISEASES; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKEMIA; LYMPHOKINES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MONOCYTES; PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER;

EID: 58549115679     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.04.050     Document Type: Article

References (31)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Charo I.F., and Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 95 (2004) 858-866
3. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
4. Rahat M.A., Marom B., Bitterman H., et al. Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J Leukoc Biol (2006)
5. Stawowy P., Meyborg H., Stibenz D., et al. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis. Circulation 111 (2005) 2820-2827
6. Millette E., Rauch B.H., Kenagy R.D., Daum G., and Clowes A.W. Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 16 (2006) 25-28
7. Tang J., Kozaki K., Farr A.G., et al. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice. Am J Pathol 167 (2005) 901-912
8. Kozaki K., Kaminski W.E., Tang J., et al. Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am J Pathol 161 (2002) 1395-1407
9. Evanko S.P., Raines E.W., Ross R., Gold L.I., and Wight T.N. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 152 (1998) 533-546
10. Ross R., Masuda J., Raines E.W., et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248 (1990) 1009-1012
11. Tanizawa S., Ueda M., van der Loos C.M., van der Wal A.C., and Becker A.E. Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study. Heart 75 (1996) 549-556
12. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., and Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 82 (1988) 1134-1143
13. Bernstein L.R., Antoniades H., and Zetter B.R. Migration of cultured vascular cells in response to plasma and platelet-derived factors. J Cell Sci 56 (1982) 71-82
14. Mancini M.C., and Evans J.T. Role of platelet-derived growth factor in allograft vasculopathy. Ann Surg 231 (2000) 682-688
15. Sihvola R., Koskinen P., Myllarniemi M., et al. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation 99 (1999) 2295-2301
16. Ponten A., Folestad E.B., Pietras K., and Eriksson U. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ Res 97 (2005) 1036-1045
17. Li X., Tjwa M., Moons L., et al. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors. J Clin Invest 115 (2005) 118-127
18. Whatling C., Bjork H., Gredmark S., Hamsten A., and Eriksson P. Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes. J Lipid Res 45 (2004) 1768-1776
19. Lee E.O., Kang J.L., and Chong Y.H. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. J Biol Chem 280 (2005) 7845-7853
20. Changsirikulchai S., Hudkins K.L., Goodpaster T.A., et al. Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int 62 (2002) 2043-2054
21. Eitner F., Ostendorf T., Kretzler M., et al. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases. J Am Soc Nephrol 14 (2003) 1145-1153
22. Lokker N.A., Sullivan C.M., Hollenbach S.J., Israel M.A., and Giese N.A. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62 (2002) 3729-3735
23. Sjolund M., Hedin U., Sejersen T., Heldin C.H., and Thyberg J. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner. J Cell Biol 106 (1988) 403-413
24. Chen J., Han Y., Lin C., et al. PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. Biochem Biophys Res Commun 329 (2005) 976-983
25. Li H., Fredriksson L., Li X., and Eriksson U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene 22 (2003) 1501-1510
26. Xu L., Tong R., Cochran D.M., and Jain R.K. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. Cancer Res 65 (2005) 5711-5719
27. Uutela M., Wirzenius M., Paavonen K., et al. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. Blood 104 (2004) 3198-3204
28. Fang L., Yan Y., Komuves L.G., et al. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Arterioscler Thromb Vasc Biol 24 (2004) 787-792
29. Hao X., Mansson-Broberg A., Blomberg P., et al. Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 322 (2004) 292-296
30. Zheng J., Shin J.H., Xaymardan M., et al. Platelet-derived growth factor improves cardiac function in a rodent myocardial infarction model. Coron Artery Dis 15 (2004) 59-64
31. Lepidi S., Kenagy R.D., Raines E.W., et al. MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I collagen. J Vasc Surg 34 (2001) 1111-1118